Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Samuel KyobeDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.ORCID 0000-0003-0444-5608
Savannah MwesigwaDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.
Gyaviira NkurunungiThe Medical Research Council/Uganda Virus Research Institute & London School Hygine Tropical Medicine Uganda Research Unit, Entebbe P.O. Box 49, Uganda.ORCID 0000-0003-4062-9105
Gaone RetshabileDepartment of Biological Sciences, University of Botswana, Gaborone Private Bag UB 0022, Botswana.ORCID 0000-0003-1721-0963
Moses EgesaThe Medical Research Council/Uganda Virus Research Institute & London School Hygine Tropical Medicine Uganda Research Unit, Entebbe P.O. Box 49, Uganda.ORCID 0000-0001-5136-868X
Eric KatagiryaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.ORCID 0000-0002-9662-2861
Marion AmujalDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.ORCID 0000-0001-7406-3926
Busisiwe C MlotshwaDepartment of Biological Sciences, University of Botswana, Gaborone Private Bag UB 0022, Botswana.
Lesedi WilliamsDepartment of Biological Sciences, University of Botswana, Gaborone Private Bag UB 0022, Botswana.
Hakim SendagireDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.
On Behalf Of The CAfGEN Consortium
Dithan KiraggaBaylor College of Medicine Children's Foundation, Kampala P.O. Box 72052, Uganda.
Graeme MardonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Mogomotsi MatshabaPediatric Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Neil A HanchardNational Human Genome Research Institute, National Institutes of Health, 50 South Drive, Bethesda, MD 20892, USA.
Jacqueline Kyosiimire-LugemwaThe Medical Research Council/Uganda Virus Research Institute & London School Hygine Tropical Medicine Uganda Research Unit, Entebbe P.O. Box 49, Uganda.ORCID 0000-0001-7868-9504
David RobinsonDepartment of Chemistry and Forensics, School of Science and Technology, Nottingham Trent University Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0000-0003-2760-7163
Funding
Phenotyping and BioarchivingU54AI110398 · NIAID · BOTSWANA BAYLOR CHILD/CLINCAL CTR/EXCELL · PI MATSHABA, MOGOMOTSI SANDY · 2014 to 2021
$8.9M
Makerere University MakRIF_PhD_SupoortNIAID NIH HHS U54 AI110398Wellcome Trust
6 · The paper itself
Abstract
Efforts towards an effective HIV-1 vaccine have remained mainly unsuccessful. There is increasing evidence for a potential role of HLA-C-restricted CD8
Indexed as
Epitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusHIV-1HLA-C AntigensAmino Acid SequenceHIV AntigensHIV InfectionsHumansProtein BindingT-Lymphocytes, CytotoxicEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusHIV AntigensHLA-C Antigensp17 protein, Human Immunodeficiency Virus Type 1HIV controlHLA-C*03:02immunoinformatics
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein. · full record | OpenQuestion